An update on somatostatin receptor signaling in native systems and new insights on their pathophysiology
Author(s)
Cervia, Davide
Bagnoli, Paola
Date Issued
2007
Type
Article
Abstract
The peptide somatostatin (SRIF) has important physiological effects (mostly inhibitory) which have formed the basis for the clinical use of SRIF compounds. SRIF binding to its five G-protein coupled receptors leads to the modulation of multiple transduction pathways. However, our current understanding of signalling exerted by receptors endogenously expressed in different cells/tissues reflects a rather complicated picture. On the other hand, the complexity of SRIF receptor signalling in pathologies, including pituitary and nervous system diseases, may be studied not only as alternative intervention points for the modulation of SRIF function but also to exploit new chemical space for drug-like molecules.
Additional information
L'articolo รจ disponibile sul sito dell'editore http://www.sciencedirect.com/
Citation
Cervia, D., Bagnoli, P. 2007. An update on somatostatin receptor signaling in native systems
and new insights on their pathophysiology. "Pharmacology & Therapeutics" 116(2): 322-341
and new insights on their pathophysiology. "Pharmacology & Therapeutics" 116(2): 322-341
File(s)![Thumbnail Image]()
Name
Cervia & Bagnoli Pharm Ther 2007 1.pdf
Size
92.39 KB
Format
Adobe PDF
Checksum (MD5)
a0f733b904f8a1ea7f347bb973c184a8